Treatment Patterns of Newly Initiated Oral Anticoagulants on Japanese Non-valvular Atrial Fibrillation Patients Using a Japanese Claims Database
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48,696
- 试验地点
- 1
- 主要终点
- Number of Patients Prescribed OAC Drug Edoxaban by Dosage
研究概览
简要总结
- To understand the treatment patterns of OACs and baseline patient characteristics of Japanese Non-Valvular Atrial Fibrillation (NVAF) patients
- To determine whether warfarin and dabigatran new user group can be balanced using propensity score matching using pre-specified baseline covariates.
- As an exploratory analysis, to assess mean duration of on-therapy follow-up time in database
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Number of Patients Prescribed OAC Drug Edoxaban by Dosage
时间窗: Day 1
Number of patients prescribed OAC drug edoxaban at the index date by dosage. If a patient had more than one prescriptions of an OAC at the day, the patient was multiple-counted.
Number of Patients Prescribed OAC Drug Rivaroxaban by Dosage
时间窗: Day 1
Number of patients prescribed OAC drug rivaroxaban at the index date by dosage. If a patient had more than one prescriptions of an OAC at the day, the patient was multiple-counted.
Number of Patients Prescribed OAC Drug Warfarin by Dosage
时间窗: Day 1
Number of patients prescribed OAC drug Warfarin at the index date by dosage. If a patient had more than one prescriptions of an OAC at the day, the patient was multiple-counted.
Number of Patients Prescribed OAC Drug Dabigatran by Dosage
时间窗: Day 1
Number of patients prescribed OAC drug dabigatran at the index date by dosage. If a patient had more than one prescriptions of an OAC at the day, the patient was multiple-counted.
Number of Patients by Each Type of Study-target OAC Drug Prescribed for New Users of Anticoagulants With NVAF
时间窗: Day 1
Number of patients by each type of study-target OAC drug (dabigatran, warfarin, apixaban, rivaroxaban, or edoxaban) prescribed as the first Oral Anticoagulants (OAC) with Non-valvular atrial fibrillation (NVAF)
Number of Patients Prescribed OAC Drug Apixaban by Dosage
时间窗: Day 1
Number of patients prescribed OAC drug Apixaban at the index date by dosage. If a patient had more than one prescriptions of an OAC at the day, the patient was multiple-counted.
次要结局
- Baseline Characteristics: Age(1 day)
- Baseline Characteristics: AF Risk Score(Day 1)
- Baseline Characteristics: Gender(Day 1)
- Baseline Characteristics: History of Hospitalization(Day 1)
- Baseline Characteristics: Concomitant Medication(Day 1)
- Baseline Characteristics: Year of Initiating Treatment(Day 1)
- Baseline Characteristics: Speciality of Prescribers of OAC(Day 1)
- Baseline Characteristics: History of Disease(Day 1)